Insights and Updates
Get the latest insights, news, press releases, case studies and more to elevate your trading game.
FlexTrade Launches New Issue Management System in Consultation with Neuberger Berman
January 23, 2024
FlexTrade Systems now empowers asset managers and multi-strat buy-side firms to streamline their new issue management workflows with FlexNIMS a fully integrated, end-to-end Equity Capital Markets solution for buy-side institutions. New York, January 23, 2024 …
-
FlexTrade Partners with RSRCHXchange for MiFID II Compliance
Execution management system provider FlexTrade announced the integration of RSRCHXchange’s research database, which alerts traders to new research relevant to their activity. It will help clients comply with MiFID II’s unbundling requirements. FlexTrade’s Andy Mahoney comments.
-
Markit Integrates TCA Data into FlexTrade’s EMS Platform
Markit today announced that it has integrated its transaction cost analysis (TCA) data into FlexTrade’s FlexTRADER EMS platform, a multi-asset portfolio and single security trading system.
-
FlexTrade Shortlisted in Three Categories of FX Week e-FX Awards 2016
FlexTrade is proud to announce its has been shortlisted in three categories of this year’s FX Week e-FX Awards 2016.
-
FlexTrade to Offer Institutional Research to FlexTRADER EMS Users Via RSRCHXchange
FlexTrade today announced its partnership with RSRCHXchange to provide buy-side traders with immediate alerts to the availability of relevant research via the company’s FlexTRADER EMS.
-
Trade Secrets
Sell-side brokers, asset managers and institutional investors are all increasingly using transaction cost analysis to reduce costs and improve regulatory compliance. Global Investor’s Paul Golden investigates. FlexTrade’s Andy Mahoney comments.
-
Credit Suisse 2016 European Equity Trading Forum (May 19 – 20, 2016)
Stop by FlexTrade’s booth for information about FlexTRADER and how it can help really deliver cross-asset trading. Also see how FlexTCA can help to achieve MiFID II compliance. We’ll also be demonstrating the recently announced integration with OTAS Technology’s live market analysis tool, and while visiting our booth you can also try out our implementation of Symphony messaging in FlexTRADER’s blotter.
-
Will the Buy-Side Become Fixed Income Liquidity Providers?
Due to liquidity constraints, are buy-side fixed income traders prepared to play a more active role as price- makers on electronic trading platforms? FlexTrade’s Ivy Schmerken investigates.
-
Borsa İstanbul VIOP to Reach Asian Investors More Easily with FlexTrade
FlexTrade, one of Asia’s most preferred software companies, became a certified member for VIOPFIX API by completing the certification at Borsa İstanbul VIOP.
-
TCA Trends: Venue Analysis Tops Buy-Side Priorities
It’s no secret that institutional traders are utilizing transaction cost analysis (TCA) for equities trading as a tool for measuring execution quality and reducing slippage against trading benchmarks. But now that TCA has matured in equities, the question is where is TCA moving next?
-
OTAS launches Lingo for Microstructure
OTAS Technologies (OTAS) today announced the launch of Lingo for Microstructure, which produces intra-day reports containing up-to-date analysis of all the standout and unusual activity in stocks. Lingo for Microstructure is available through FlexTrade’s execution management system, FlexTRADER.
-
FlexTrade Expands Sales Presence in APAC Region
FlexTrade Systems today announced the appointments of Tim Wong, Maroof Khan and Dan Enstedt as VP’s of Business Development, Multi-Asset Sales, for the company’s APAC region. The new team will cover North Asia, South East Asia and Australia / New Zealand, respectively.
-
A Tale of Two Pilots: Maker-Taker and the Tick Pilot
Senators conducting a hearing on U.S. equity market structure earlier this month vented their frustrations at the slow pace of regulatory change in equity market structure reforms. At the March 3 hearing, lawmakers repeatedly cited delays in developing the consolidated audit trail, or CAT system, for market-wide surveillance, questioning to what extent progress has been made.